NUMIZOX

Product Overview

NUMIZOX CREAM contains Lidocaine I.P. 2.5% w/w + Prilocaine I.P. 2.5% w/w and is supplied as a topical cream in a 10 g pack. The formulation combines lidocaine and prilocaine, two local anaesthetic agents used in topical preparations.

NUMIZOX is presented for pharmaceutical distribution and healthcare trade requirements. Its composition, strength, dosage form and pack size are clearly specified for pharmaceutical distributors, stockists, retailers, healthcare trade professionals and franchise applicants who need to verify the exact formulation before making a business enquiry.

Availability and Franchise Enquiries

Contact the Positive Medicare team for the latest pack presentation, order quantity, territory availability and commercial terms. Pharmaceutical distributors and prospective franchise partners can enquire about product availability and related pharmaceutical business opportunities.

Important: This page is intended for healthcare professionals and pharmaceutical business enquiries. It does not provide individual treatment, application or dosage advice. Products containing local anaesthetic agents should be used according to approved product labelling and under the direction of a qualified healthcare professional.